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Abstract: This paper describes the optimal implementation of three newly conceived 
sensors for both health and environmental applications, utilizing a wide range of detection 
methods and complex nanocomposites. The first one is inorganic and based on matrices of 
calcium oxide, the second is based on protein arrays and a third one is based on   
Langmuir-Blodgett laccase multi-layers. Special attention was paid to detecting substances 
significant to the environment (such as carbon dioxide) and medicine (drug administration, 
cancer diagnosis and prognosis) by means of amperometric, quartz crystal microbalance 
with frequency (QCM_F) and quartz crystal microbalance with dissipation monitoring 
(QCM_D) technologies. The resulting three implemented nanosensors are described here 
along with proofs of principle and their corresponding applications. 
Keywords: QCM_D; protein-protein interaction; calcium oxide matrices; CO2;  
Langmuir-Blodgett; laccase; amperometry; clomipramine 
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1. Introduction 
This paper describes the utilization of a wide range of complex nanocomposites [1] for optimal 
implementation of three newly conceived sensors within the framework of FIRB Nanoitalnet. We used 
inorganic nanocomposites, such as matrices of calcium oxide [2], and biological ones such as Nucleic 
Acid Programmable Protein Arrays (NAPPA) [3,4] along with Langmuir-Blodgett (LB) multi-layers 
of proteins of primary interest such as laccase [5,6]. Special attention was paid to the detection of 
substances significant for both the environment (such as carbon dioxide) and medicine (drugs   
and cancer) by means of a wide variety of detection methods (amperometric, conductometric,   
and nanogravimetric).  
The resulting three organic and biological constructed nanosensors, here presented in their final 
versions, were optimized on the outcome of their proof of principles studies and applied for three pilot 
cases, two for health use and one for the environment. However, all three nanosensors have prominent 
medical implications, since it is well known that there is a strong link between environment and health 
and that, according to the WHO (World Health Organization), at least 25% of diseases are due to 
environmental risk factors. 
Sensors for detection of CO2 [2] can be useful to reveal the increased emissions of gases from fossil 
fuel combustion, industrial processes, and agriculture associated to deforestation and habitat 
destruction. This can result in consequent changes in the chemical composition of the atmosphere with 
direct biological effects and negative influence on the Earth’s climate [2] considering that fossil fuel 
CO2 emissions can remain in the atmosphere for periods of up to tens of thousands of years. The 
instruments generally employed in these determinations basically consist of infrared (IR) detectors 
performing a continuous plotting in the site with a good degree of accuracy, but they cannot be used 
for extensive mapping work because of the large number of expensive devices and specialized people 
that would have to be involved. Long-term sampling devices such as diffusive sampling techniques are 
the cheapest and easiest way. 
An alternative long-term sampling method for the determination of environmental CO2 
accumulation takes advantages of the properties of CaO to be carbonated by this gas as shown in 
reference [2], according to the following equation: 
CaO + CO2 CaCO3   (1)
For this purpose, we studied here the variation of mass connected to the carbonation process in 
order to assess the quantity of gas absorbed by a fixed amount of composite in relation to the 
concentration of environmental CO2. 
For what concerns the two health prototypes [3,5], one biosensor of new conception was realized by 
coupling the traditional quartz crystal microbalance with frequency monitoring (QCM_F) [7] with the 
quartz crystal microbalance with dissipation monitoring (QCM_D) [8,9], and with an innovative 
protein cell-free expression system named Nucleic Acid Programmable Protein Arrays   
(NAPPA) [10,11], that allowed us to immobilize on the quartz surface, as sensing molecule, any kind 
of protein [3]. In the QCM_D sensor [12] each quartz contained 4x4 NAPPA spots of 300-micron 
square and functional proteins were synthesized in situ directly from printed cDNAs (complementary 
DNAs) just before the assay [4,12]. Standard nanogravimetry exploited the piezoelectric quartz Sensors 2012, 12 17114 
 
crystals’ properties to vary the resonance frequency, f, when a mass, Δm, was adsorbed to or desorbed 
from their surface according to the Sauerbrey equation: 
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where f0 is the fundamental frequency, A is the gold area and ρ and l are the quartz density and 
thickness, respectively [7–9]. Quartz resonators used in fluids are more than mere mass or thickness 
sensors; sensor response depends also on the viscoelastic properties of the adhered biomaterial, surface 
charges of adsorbed molecules and surface roughness. The modern QCM_D technology utilizing 
impedance measurement (as in the sensor introduced in references [3,12]) offers access to the 
resonance bandwidth in addition to resonance frequency. Bandwidth value is strictly connected with 
the viscoelastic properties of the sample [8,9]. Building upon the successful use of in vitro  
NAPPA- translated protein, Ramachandran et al. substituted the use of purified proteins with the use 
of cDNAs encoding the target proteins at each feature of the microarray [10]. The proteins were 
translated using a T7-coupled rabbit reticulocyte lysate in vitro transcription-translation (IVTT) 
system. Mammalian proteins can be expressed in a mammalian milieu, providing access to vast 
collections of cloned cDNAs. The addition of a C-terminal glutathione S-transferase (GST) tag to each 
protein enabled its capture on the array through an antibody to GST printed simultaneously with the 
expression plasmid [10,11]. In the present research, we coupled QCM_D and QCM_F with NAPPA 
technology [3,12], optimizing the monitoring in real time of the kinetics of the reaction to obtain 
information not only concerning the mass, but also on the viscosity of the sample and sensing the 
interaction among a query protein and the expressed protein.  
The proteins monitored by the NAPPA-based nanogravimetric biosensor, namely p53 and MDM2, 
are of fundamental importance in the molecular mechanisms leading to malignant cell transformation 
and cancer; p53 is in fact a 53-kiloDalton phosphoprotein oncosuppressor, encoded by a 20-kilobases 
gene situated on the short arm of human chromosome 17 and termed as the “guardian of the genome” 
and the “policeman of oncogenes” [13,14]. Mutated, it is involved in up to 70% of human tumors, 
being responsible of cell growth arrest, senescence, apoptosis in response to an array of stimuli such as 
DNA damages (DSB, or double-strand-breaks), hypoxia, telomeres shortening, cell adhesion, 
oncogene activation and other molecular and cellular stresses [15]. MDM2, a p53-specific E3 ubiquitin 
ligase, inhibits p53 functions by binding to its N-terminal transcription-promoting domain, thus having 
an oncogenic activity. The MDM2-p53 plays a major role in cancer, being also a molecular therapeutic 
target and its monitoring is of crucial importance in cancer diagnosis and treatment [16]. 
In this report, our goal was finally to build the prototype of the enzyme-based biosensor for medical 
purposes, in which the immobilization procedure was carried out via Langmuir-Blodgett films. The 
enzyme implemented in our device [5] was laccase [6], which is a blue oxidase capable of oxidizing 
phenols and aromatic amines by reducing molecular oxygen to water by means of a full complement of 
copper atoms. Laccase belong to a large group of multicopper enzymes, which includes among others 
ascorbic acid oxidase and ceruloplasmine. They catalyze the oxidation of diverse compounds such as 
o-, p-diphenols, aminophenols, polyphenols, polyamines, lignin, some inorganic ions, aryldiamines, 
benzenthiols, and phenothiazines. Sensors 2012, 12 17115 
 
2. Materials and Methods 
Taking into account all the considerations so far discussed and the three sensors recently introduced 
in the literature [2,3,5], in this section we summarize the techniques and procedures utilized in the 
construction of the three distinct prototypes. 
2.1. Inorganic Sensor Based on Matrices of Calcium Oxide 
The alternative long-term sampling method for the determination of environmental CO2 
accumulation takes advantages of the properties of CaO to be carbonated by this gas. We carried out 
preliminary tests to assess the best concentration of CaO in the composite, individuated in the 
CaO/PEG weight ratio of 1/4, by studying the variation of mass connected to the carbonation process, 
in order to assess the quantity of gas absorbed in relation to the concentration of environmental CO2 by 
a fixed amount of composite. We tested the sensing properties of the composite materials via a 
nanogravimetric method by using a home-made glass chamber of 340 mL in volume [2]. The   
home-made chamber was provided with four input sockets able to arrange up to four quartzes at the 
same time, besides inlet and outlet valves to feed and empty the gas. As transducers, AT-cut quartz 
crystals were used, with a native frequency equal to 9.5 MHz, a blank diameter equal to 0.550”, an 
etched surface, an electrode diameter equal to 0.295”, with 100 Å Cr and 1000 Å Au as electrode 
materials (International Crystal Manufacturing Co, Inc., ICM, Oklahoma City, OK, USA). The 
preliminary experimental data highlighted that the composite was able to selectively detect CO2 via a 
nanogravimetric method by performing the experiments inside an atmosphere-controlled chamber 
filled with CO2 [2]. Furthermore, the composite material showed a linear absorption of CO2 as a 
function of the gas concentration inside the atmosphere-controlled chamber, thus paving the way for 
the possible use of these matrices for applications in the field of sensor devices for long-term 
evaluation of accumulated environmental CO2. In reference [2] are illustrated the experimental results 
obtained from these experiments. 
The previous reported considerations allowed us to design and realize a dosimeter for the long-term 
analysis of the carbon dioxide. We used the same transducers but they were inserted in a home-made 
and ad hoc designed and built Plexiglas measuring chamber, divided into two parts: the upper one, 
with a funnel opening, allowed the exchange of the sensing matrix with the environment and the lower 
one that allowed the housing of the transducer (Figure 1). 
The nanogravimetric instrument used for relating CO2 concentrations with mass variations 
consisted of a base unit, interfaced to a PC via USB port and able to drive up to four oscillator  
units [2]. The base unit embedded the interface circuitry to/from the USB port, a digital signal 
controller and a fast programmable logic device containing an accurate four-channel counter, plus the 
four interfaces to the oscillator units. The counter logic was fully parallel, this meaning that the four 
input signals were acquired and counted-up simultaneously at a gate interval selectable from fractions 
of a second to 10 s. The base unit was powered by means of an external pluggable +12 V power supply 
which sustained input AC voltages from 90 to 240 VAC (Figure 2). Sensors 2012, 12 17116 
 
Figure 1. Illustration of the plastic cell containing the quartz for environmental CO2  
long-term sampling, constructed in cooperation with Elbatech Srl, Marciana, Italy. 
 
The choice to have the oscillators outside the base unit allows the maximum flexibility when 
building an experimental set-up. The noise immunity was preserved and guaranteed by the oscillator 
design, which was based on a precision internal reference crystal, used as a timebase comparator for 
the working quartz crystal. Only the mixed, lower frequency signal was then transmitted to the base 
unit by dedicated twisted pair lines on the cable. The oscillator units were connected to the base unit 
by means of standard Ethernet class V cables (see Figure 2 below). 
Figure 2. Nanogravimetric base-unit, able to drive up to four oscillating units (Upper). 
Oscillators unit connected via Ethernet cable to the base unit (Lower). 
 
The system was driven by an extremely user-friendly software running under MS-Windows
TM. It 
consisted of a lower level kernel, which implemented the necessary data transfer between the computer 
and the base unit, and of a higher level set of routines, which drove the user through an easy to perform 
data acquisition and analysis. In addition to the data acquisition service routine, a useful data display 
was implemented by which the user was easily able to retrieve the acquired signal values. Oscillating 
frequency versus time measurements can be performed following the data acquisition in real time on 
the computer screen, by means of strip chart plotting. 
Screw
CO2 access
Quartz for nanogravimetric acquisitionsSensors 2012, 12 17117 
 
2.2. Biological Sensor Based on NAPPA and QCM_D Technology 
Our system, shown in Figure 3, detects the normalized dissipation factor of the quartz crystal by 
means of the “half-width half-height” of its impedance curve [3]. In our case, the quartz was connected 
to an RF gain-phase detector (Analog Devices, Inc., Norwood, MA, USA) and was driven by a 
precision Direct Digital Synthesizer (DDS, Analog Devices, Inc.) around its resonance frequency, thus 
acquiring conductance vs. frequency curve, which showed a typical Gaussian behavior [3]. 
Figure 3. QCM_D biosensor prototype scheme. The quartz was positioned in a flow 
chamber that also guaranteed the temperature control. Temperature and flux rate were 
settable trough the controllers and D factor and frequency values are visible on two 
displays. On connecting the instrument to a PC it is possible to record the impedance 
curves, the frequency and D factor shifts in real time. 
D factor Frequency
Personal Computer 
connection
Temperature and flux controllers
Temperature
Displays
Temperature/flow chamber           
(with inside the quartz)
Flux
D factor Frequency
Personal Computer 
connection
Temperature and flux controllers
Temperature
Displays
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The curve peak was at the actual resonance frequency while the shape of the curve indicated how 
damped was the oscillation, i.e., how the viscoelastic effects of the surrounding layers affected the 
oscillation. In order to have a stable control of the temperature, the experiments were conduced in a 
temperature chamber. The experimental set up, illustrated by the scheme in Figure 3, consisted of a 
temperature chamber were the quartz was positioned and monitored at the same time for frequency and 
dissipation factor variation. We designed a miniature flow-cell (Figure 4) to employ in protein-protein 
interaction analysis. The flow cell chamber volume was 100 μL and it was connected to a BioRad 
Econo Gradient Pump, able to pump solution in a flux range of 0.02–6 mL/min. 
Figure 4. Plexiglas chamber utilized during the flow analysis of protein-protein 
interaction: the upper part, with the flow inlet and outlet, allowed the easy insertion of the 
biological fluid to be analysed and the lower allowed the proper housing of the quartz. 
 Sensors 2012, 12 17118 
 
The transducer consisted of 9.5 MHz AT-cut quartz crystal of 14 mm blank diameter and 7.5 mm 
electrode diameter, produced by ICM. The electrode materials were 100 Å Cr and 1,000 Å Au. 
Microarrays were produced on the quartzes already described as highly sensitive transducers. Each 
quartz was printed with 4 × 4 NAPPA spots of 300 microns diameter, spaced 350 microns   
center-to-center [4], using the given genes and corresponding expressed proteins. The blank quartz was 
sent to the Harvard Institute of Proteomics (HIP) for the NAPPA spots printing as described in [3,4]; 
in order to express proteins we adopted the protocol described in [10]. Gene expression and protein 
synthesis took place at 30 °C for about 1.5 h; to prepare rabbit reticulocyte lysate mix (Expression Kit, 
Promega, Madison, WI, USA) we mixed 16 μL of TNT buffer, 8 μL of T7 polymerase, 4 μL of Cys,  
8 μL of RNaseOUT (Invitrogen, Carlsbad, CA, USA), 160 μL of DEPC water (Ambion, Foster City, 
CA, USA), and 200 μL of reticulocyte lysate (TNT® T7 Coupled Reticulocyte Lysate System, 
Promega). Sixty μL of IVT lysate mix was added per quartz. The quartz, connected to the 
nanogravimeter inside the incubator, was incubated for 1.5 h at 30 °C for proteins synthesis and then, 
the temperature was decreased to 15 °C for a period of 0.5 hour to facilitate the proteins binding on the 
spot surface. The quartz was subsequently removed from the instrument and washed three times at 
room temperature (22 °C) in Milli-Q water. The quartz was then placed in the flux chamber for 
protein-protein interaction analysis. The protocol described above was followed identically for both 
control quartz (blank quartz) and working quartz. The proofs of principle to verify sensor response to 
NAPPA protein expression and immobilization were carried out immobilizing the following genes and 
corresponding expressed proteins: CDK2_Human gene, jun_Human gene and p53_Human gene [17]. 
As reference, a blank quartz was employed. For protein-protein interaction proof of principle, we 
tested the interaction between p53 proteins immobilized on the NAPPA surface (after its expression) 
with a MDM2 solution. In parallel experiments (submitted elsewhere as a result of a cooperation with 
the Biodesign Institute at the Arizona Institute of Proteomics) several other genes of significant clinical 
and biological implication and others configurations (10 × 10 spots) were tested. In particular 
CYP11A1_Human genes were immobilized and cholesterol was chosen for interaction analysis and 
their comparison with similar cholesterol sensors based on traditional technologies [18,19]. 
2.3. Biological Sensor Based on Langmuir-Blodgett Multi-Layers of Laccase 
A LB thin film [20] of recombinant laccase from Rigidoporus lignosus (formerly known as 
Rigidoporus microporus), obtained as previously reported [6], was prepared using a highly 
concentrated sample of laccase. The mixed chloroform solution in equimolar proportions had a 
concentration of 1 mg/mL. A volume of 50 μL of the mixture was spread on a Milli-Q water sub-phase 
(>17 MΩ) and the monolayer was compressed with movable barriers at a rate of 70 mm/minute. The 
deposition was of Y-type with a dipping rate of 25 mm/min. The drainage rate (in order to remove the 
film) was about 3.5 mm/min. The transfer pressure to obtain the LB film (Figure 5) was about   
20 mN/m, at 22 °C. 
The surface morphology and topology of the LB thin film of laccase was investigated via Atomic Force 
Microscopy (AFM) [5]. The roughness of the film was found to be 8.22 nm and the compressibility 
coefficient about 37.5 m/N as determined from the LB π-A isotherm at the air-water interface   
(Figure 5, Left). The enzyme was deposited onto the electrode via Langmuir-Schaefer (LS) technique [5] Sensors 2012, 12 17119 
 
and a protocol of immobilization overnight was followed; after depositing the film, the electrodes (Figure 
5, Right) were kept at 4 °C up to a maximum of 16 hours. The employed electrodes were ruthenium and 
graphite ones, while the counter-electrode was of silver. The area of the electrode was about 0.75 mm per 1 
mm. The amperometric technique was used to polarize the electrochemical couple and to obtain a current 
discharge related to the amount of the investigated drug, namely clomipramine [5–21], with an EG & G 
PARC model 263A potentiometer, equipped with dedicated software. 
Figure 5. π-A isotherm of the laccase thin film at the air-water interface (Left). A couple 
of screen-printed electrodes used as a transducer based on graphite/ruthenium ink and the 
counter on silver one (Right). 
 
3. Results and Discussion 
3.1. Inorganic Sensor Based on Matrices of Calcium Oxide 
We performed nanogravimetric acquisitions of frequency vs. time in order to assess the variation of 
mass at regular intervals of time after placing the small plastic cell in a room. We also measured the mass 
of the deposited sample at time zero, in order to have the value of frequency related to the composite 
before reacting with environmental CO2. We consequently carried out acquisitions of frequency vs. time 
in order to sample the indoor environmental CO2 in the room, illustrated in Figure 6. 
Basing on our previous experiments [2], we were able to calculate the variation of mass per week 
and consequently the average quantity of CO2 in the environment. Experimental data, summarized in 
Table 1 for a clear vision, highlighted the variation of frequency in relation to the quantity of CO2 
absorbed by the composite issued a linear absorption, coherently with the constant human activity of 
the sampling period. Specifically, we found the variation of mass in relation to the quantity of CO2 
present in the environment (indoors), indicated the concentration of indoor CO2 during the sampling 
period was 10 times less than the average concentration in the atmosphere, thus indicating the good 
quality of the air in our laboratory. 
Since the very good results were obtained from the usage of this long-term sampling device, we are 
presently programming new samplings both in indoor spaces affected by strong human activities   
and outdoors. Sensors 2012, 12 17120 
 
Figure 6. Variation of frequency in relation to the quantity of CO2 absorbed by the 
composite. Experimental data showed a linear absorption, coherently with the human 
activity of the sampling period.  
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Table 1. Variation of mass in relation to the quantity of CO2 present in the environment 
(indoor). The concentration of indoor CO2 was found 10 times less than the average 
concentration in the atmosphere, thus indicating good quality of the air. 
Sampling Period (days)  Variation of Mass Δm (μg)  Concentration of Environmental CO2 (ppm) 
7  0.57 ± 0.007  48 ± 1 
7  0.72 ± 0.007  55 ± 1 
7  0.75 ± 0.007  55 ± 1 
3.2. Biological Sensor Based on NAPPA and QCM_D Technology 
The QCM_D results were calibrated both for frequency and D factor shifts using fructose [3,4]. We 
monitored by QCM-D the viscoelastic behaviour of the quartzes during the NAPPA expression 
process, recording the impedance curves in correspondence with the main steps of the expression 
process. Moreover we monitored by QCM-F the variation in the mass adsorbed on the surface of the 
sensors (corresponding to a decrease of the resonance frequency). Figure 7 Left shows the impedance 
curves of p53 quartz at different steps of the expression protocol, as following: 
•  At the beginning of the expression process, i.e., before reticulocyte lysate addition; 
•  120 min after reticulocyte lysate addition (i.e., after 90 min at 30 °C for gene expression and 
protein synthesis plus 30 min at 15 °C for protein immobilization) and after washing process,  
at 22 °C; 
•  After the addition of a MDM2 50 μM solution. 
In order to investigate the biosensor response to protein-protein interaction the p53 quartz, once 
expressed the proteins, was positioned in the flux chamber, connected with the pump, and a MDM2 
solution was flowed on the quartz surface: 2 mL of 50 μM MDM2 solution in PBS was injected in the 
pump. The corresponding frequency decrease was recorded (Figure 7, Right). Sensors 2012, 12 17121 
 
Figure 7. (Left) p53 quartz impedance curves recorded before the gene expression (solid 
curve), after the protein expression and the washing process (dashed curve) and after 
MDM2 addition (dotted curve); (Right) p53 quartz frequency variation in real time; at time 
t = 600 s a MDM2 solution (50 μM in PBS) was injected in the flow chamber. 
 
In Table 2 are reported for p53 quartz impedance curves of Figure 7, Left, the values of the 
frequency and the half width at half height (Γ), along with the values of the variation in conductance 
YRE (mS). The ratio named normalized D factor, DN = 2Γ/I, gives information on the shape of 
impedance curves and on sample viscosity, while the decrease in frequency f (Hz) is related to the 
amount of p53 molecules being immobilized. 
Table 2.  Peak frequency (f), half-width at half-height (Γ), maximum conductance 
increment (YRE), and normalized D factor for the impedance curves shown in Figure 7 Left. 
Impedance Curve  f (Hz)  Γ (Hz)  YRE (mS)  DN (Hz/mS) 
Beginning 9475435  2220  0,415  10699 
After protein expression and washing  9470905  3705  0.310  23903 
After MDM2 addition  9467860  3600  0.135  53333 
The resulting Michaelis-Menten constants of the p53-MDM2 (calculated from the curve in   
Figure 7, Right) interaction appeared quite compatible with the literature.  
The results mentioned before obtained using a human lysate and 10 × 10 spots per quartz reported 
in a separate communication (pending submission to a different journal) suggest that the NAPPA 
based biosensor functioned to monitor with high selectivity the single protein being expressed even in 
a mixture of different genes (as shown here in Figure 7, Right) and, from the analysis of D factor, 
allowed to acquire in real time information on the characteristics both of single protein being 
expressed with unique signature and on the kinetic constant of the reaction.  
In order to properly set-up the QCM_D for routine measurements, we are going to immobilize the 
NAPPA on the given reference quartzes provided by the manufacturer [4]. Then, in order to eliminate 
the background signal, we are going to routinely carry out the measurements starting from the crystal 
native frequency subtracted of 15 kHz and using a step of 1.0 Hz for collecting whole impedance plots 
at the necessary resolution and with a considerable number of data points. For this reason, we have 
used a dsPIC (Microchip Technology, Inc., Chandler, AZ, USA) featuring at the same time good 
computational power and sufficient memory space. This represents a PC-driven prototype to establish Sensors 2012, 12 17122 
 
the proof of principle. The industrial prototype is being designed and realized, under a different 
contract with significant larger amount of money than here provided by the MIUR under the indicated 
FIRB contract, in order to have a temperature-controlled ad hoc chamber, hardware and software 
optimized to increase speed, computational power and compactness to incorporate hardware, in order 
to produce a finalized friendly stand-alone device. 
3.3. Biological Sensor Based on Langmuir-Blodgett Layers of Laccase 
Clomipramine [21,22], a drug belonging to the tricylic tertiary amine antidepressants class, is 
widely used for the therapy of depressive and obsessive disorders. Because of its clinical importance 
many analytical methods have been developed to monitor its levels, above all chromatographic 
techniques (gas chromatography, high performance liquid chromatography), eventually coupled with 
tandem mass spectrometry, but all these techniques are time-consuming and laborious. Moreover, the 
AGNP-TDM panel of experts has emphasized the importance of therapeutic drug monitoring [23]. In 
our experiment, clomipramine was added at varying concentrations in the micromolar range. The 
therapeutic dose is from 75 mg/day to 200 mg/day; the pharmacokinetics among patients is extremely 
variable. Generally, the therapeutic concentration in the human blood of psychiatric patients is usually 
in the low micromolar range. The side-effects of the drugs, especially in case of overdose, are seizures, 
hematological, cardiological and neurological adverse effects up to the coma (tricyclic antidepressant 
syndrome, [24]). Experiments carried out with cyclic voltammetry (see Figure 8) highlighted excellent 
reproducibility and linearity of the peaks of oxidation and reduction, related to the presence of the drug 
in several biological fluids (in particular in whole blood). 
Figure 8. Cyclic voltammetry of laccase-based biosensor for detection of clomipramine at 
increasing concentrations in human blood. 
 
These results allowed the design and the creation of a prototype of a biological sensor for 
antidepressants. The instrument consisted of a central unit, able to bias the working electrode on which 
the enzyme was deposited and to detect the current generated as a result of the interaction of the Sensors 2012, 12 17123 
 
enzyme with the analyte containing the drug of interest. By a multiple selector, the user can choose the 
fluid to be analyzed and, through the proper calibration parameters, on the display, the proper drug 
concentration will be provided. The instrument was powered by two 9V batteries, in order to avoid 
noise from the mains voltage (see Figure 9). 
Figure 9. Prototype of laccase sensor jointly constructed with Elbatech Srl, Marciana (LI), 
Italy, compact and portable for all fluids indicated in Table 3. 
 
Use of commercial laccase, screen-printed electrodes technique and a portable device appear to 
provide an emerging instrument suitable for investigation in biological fluids as well as for other 
medical applications. The same enzyme and the same proposed device could be used also in many 
different fields, such as in degradation of polyaromatic hydrocarbons, in textile industry, in food 
industry and in waste detoxification. Laccase-based sensors for detection of clomipramine in breast 
milk, saliva and semen were less sensitive than the others, while sensors for the monitoring of the drug 
level in urine and blood had better pronounced and separated peaks (as shown in Table 3). 
Table 3. Peak potentials and sensitivity of Laccase-based biosensor measured at increasing 
concentrations in different human biological fluids. 
Fluid Peak  (mV)  Sensitivity 
Blood +75;  −150   191.91 mA/M 
Urine +100;  −150   138.93 mA/M 
Liquor +100;  −200   31.70 mA/M 
Breast-milk +100;  −200   9.80 mA/M 
Saliva +150;  −100   11.14 mA/M 
Sperm +110;  −220   19.00 mA/M 
Moreover, if we compare these results with our previous findings we can study how changes in 
thickness and in number of layers can increase the functionality of a biosensor: the sensitivity of the 
biosensor in blood with LB 3-layers was more than the double of the value found here with only one Sensors 2012, 12 17124 
 
layer. It is known in fact that highly ordered structured biofilm can increase the sensitivity and the 
electron kinetics transfer (difference in the width between the oxidation and reduction peaks). 
4. Conclusions 
In summary, our resulting prototypes appear to yield satisfactory proof of principles in the shown 
specific health and environmental applications. Indeed, to measure CO2, we have realized a new 
device based on the use of a sensor technology (such as the nanogravimetric one) and an array of 
capture, highly specific for the gas of interest. Calcium oxide may be considered a valid solution to 
solve the problem of the detection of carbon dioxide due to its ability to selectively absorb this gas 
through a chemical carbonation reaction. The carbonation reaction leads to a substantial variation of 
the molecular weight and was therefore taken into account in the manufacture of gravimetric detection 
devices. The characteristics of the reaction allowed the construction of a dosimeter for the long-term 
analysis of the carbon dioxide, competitive with respect to the devices already available on the market 
based on infrared measurements (CO2 reduces the incidence of infrared radiation on the sensor, then, 
depending on the concentration of CO2) or on measurements of the variations of a voltage across a 
solid electrolyte depending on the concentration of CO2.  
For what concerns the NAPPA QCM_D conductance device the results presented demonstrated a 
valid response for the protein-protein interaction analysis, exploiting the great advantage of this 
technique that allowed the real-time, label-free characterization of molecular binding kinetics to an 
immobilized receptor. A proof of principle was realized immobilizing p53 plasmid, resulting in a 
biosensor for MDM2. The most challenging prospective of the innovative biosensors emerging from 
this technology is the potential capability to develop a large number of sensors for molecules of 
biological and medical interest, by simply changing the cDNA immobilized on the sensor, without 
changing the detection technology. Among the avenues being presently explored NAPPA-based 
vaccines identification appears to represent an additional promising future perspective in the frame of 
the new OMICS-based Public Health. Vaccinology has emerged as a complex interdisciplinary 
science, especially because of the contributions of the new OMICS disciplines [25]. In addition to 
what was anticipated some time ago [26], only recently were protein arrays used to discover new 
antigenic determinants for vaccine development [27,28]. NAPPA-based sensors could be used for 
screening the affinity between the identified proteins and the immunological synapse (CD4, TCR, 
MHC complex). Affinity kinetics can be evaluated also using classical techniques, or new efforts to 
evaluate it via Atomic Force Microscopy (AFM) and Surface Plasmon Resonance (SPR). In the   
right column of Table 4 are shown the genes that interact with immunological human synapse   
(CD4 + TCR + MHC). 
Finally, with the designed and realized amperometric sensor [5], in order to offer a suitable 
instrument for routine medical application, we used only one layer of commercial laccase to fully 
characterize clomipramine pharmacokinetics in different biological fluids of relevant medical interest, 
namely human blood, saliva, urine, breast-milk, semen and cerebro-spinal fluid or liquor (CSF). Sensors 2012, 12 17125 
 
Table 4. Genes which interact with immunological human synapses. 
Microorganism Antigen 
Pseudomonas aeruginosa 
PA0044, PA0807, PA0973 (OprL), PA1080, PA1148, PA1248, PA2300, 
PA3407, PA3724, PA3841 (ExoS), PA3931, PA4110, PA4922, PA5369, FlicA, 
OprI, OprH2, OprE, OprF, exotoxin A, flagellin 
Vibrio cholerae 
Protein 1 (VC1085), 2 (VC2283), 3 (VC1893), 4 (VC2261), 5 (VC0339, PSD), 
6 (VC1494), 7 (VC0556), 8 (VC0975) 
Yersinia pestis  VA (V antigen), F1 antigen 
Francisella tularensis  O-antigen 
Bacillus anthracis  PA (protective antigen) 
As far as we know, this is the first comprehensive characterization of clomipramine concentration 
in different biological fluids of medical interest, since drug monitoring in different biological samples 
is very important. Biological fluids were taken from healthy donor volunteers, who gave their 
informed consent, and analyzed immediately after being collected. The motivation of studying 
electrochemical behavior of clomipramine in different biological fluid of clinical interest was to 
provide a comprehensive pharmacokinetic profile. Schimmell et al. [29,30] studied drug plasma levels 
in a breast-fed infant whose mother had taken clomipramine during pregnancy and continued after 
giving birth. They found that levels were high following delivery but decreased gradually and were at 
the lowest detectable concentration at 35 days, even though breast-feeding continued. Clomipramine 
has been used by breast-feeding mothers without adverse effects on the newborn, even if drug 
monitoring in human breast milk is of crucial importance. Urine is a biological flood that can be easily 
obtained with great acceptability from the patient and can help in rapid assessment and screening in 
emergency situations [31]. CSF fluid can be exploited for monitoring the neurochemical changes 
during therapy or disease [32,33]. As far as semen is concerned, there were some communications of a 
relationship between clomipramine level in sperm and male infertility: clomipramine seems to modify 
sperm motility in a significant way, but these findings are controversial and need to be confirmed by 
further research. Moreover, clomipramine concentrations in blood, urine and liquor correlate with 
patient response state, which is the most important clinical parameter for the assessment of drug 
functionality and working. 
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